Patents by Inventor Gerrit Hauck

Gerrit Hauck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190241505
    Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4?-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
    Type: Application
    Filed: August 20, 2018
    Publication date: August 8, 2019
    Inventor: Gerrit Hauck
  • Patent number: 10029011
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 24, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20180200370
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 3, 2017
    Publication date: July 19, 2018
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20170247319
    Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4?-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
    Type: Application
    Filed: October 11, 2016
    Publication date: August 31, 2017
    Inventor: Gerrit HAUCK
  • Publication number: 20140235888
    Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4?-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
    Type: Application
    Filed: April 30, 2014
    Publication date: August 21, 2014
    Applicant: SANOFI
    Inventor: Gerrit HAUCK
  • Patent number: 8802735
    Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4?-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: August 12, 2014
    Assignee: Sanofi
    Inventor: Gerrit Hauck
  • Patent number: 8795226
    Abstract: A cannula assembly (10) comprising a hub (76) and a cannula (12) mounted in the hub (76). The cannula defines an inner space (36). The cannula comprises a distal end (16) and a proximal end (18). A first medicament (40) is provided in the inner space of the cannula. In one arrangement, the hub of the cannula assembly is configured to be coupled to an injection device (26). The cannula assembly may be removably or permanently coupled to the injection device containing a second medicament (17).
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: August 5, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Bernd Kuhn, Gerrit Hauck
  • Publication number: 20130079279
    Abstract: Subject of the present invention is A pharmaceutical composition comprising (a) desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, and (b) insulin glargine or/and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 27, 2011
    Publication date: March 28, 2013
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Reinhard Becker, Gerrit Hauck
  • Publication number: 20120295846
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 22, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Publication number: 20120252724
    Abstract: The invention relates to an aqueous pharmaceutical formulation having insulin, an insulin analog, or an insulin derivative, and methionine; and to the production thereof, to the use thereof for treating diabetes mellitus, and to a medication for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 4, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Isabell Schoettle, Annika Hagendorf, Christiane Fuerst, Gerrit Hauck, Verena Siefke-Henzler, Walter Kamm, Julia Schnieders
  • Publication number: 20120232002
    Abstract: Aqueous pharmaceutical formulations with an insulin analog, comprising 0.001 to 0.2 mg/ml of zinc, 0.1 to 5.0 mg/ml of a preservative, and 5.0 to 100 mg/ml of an isotonicity agent, and whose pH is 5 or less, and also their preparation, use for treating diabetes mellitus, and a medicament for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: September 13, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Isabell Schoettle, Christiane Fuerst, Verena Siefke-Henzler, Gerrit Hauck, Walter Kamm, Julia Schnieders, Jutta Carls, Gert Wolf
  • Publication number: 20120208880
    Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4?-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
    Type: Application
    Filed: March 16, 2012
    Publication date: August 16, 2012
    Applicant: SANOFI
    Inventor: Gerrit HAUCK
  • Publication number: 20120197210
    Abstract: A cannula assembly (10) comprising a hub (76) and a cannula (12) mounted in the hub (76). The cannula defines an inner space (36). The cannula comprises a distal end (16) and a proximal end (18). A first medicament (40) is provided in the inner space of the cannula. In one arrangement, the hub of the cannula assembly is configured to be coupled to an injection device (26). The cannula assembly may be removably or permanently coupled to the injection device containing a second medicament (17).
    Type: Application
    Filed: June 24, 2010
    Publication date: August 2, 2012
    Applicant: Sanofi-Aventis Deutschland GmbH
    Inventors: Bernd Kuhn, Gerrit Hauck
  • Publication number: 20120191066
    Abstract: A method and system for proving a cannula arrangement (4) for an injection device. The cannula arrangement comprises a limiting element (16) and a housing configured to attach to the injection device. The housing and the limiting element define a compressible reservoir (40). A second medication (26) is provided in the reservoir. A first cannula (12) comprises a piercing end (20) configured for fluid engagement with a medication provided in the injection device and a distal end (22) configured for fluid engagement with the reservoir. A second cannula (14) comprises a proximal end (48) for fluid engagement with the second medication and a piercing distal end (50) for the injection to a patient.
    Type: Application
    Filed: June 24, 2010
    Publication date: July 26, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Michael Schabbach, Daniel Wagner, Gerrit Hauck
  • Publication number: 20120172427
    Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4?-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
    Type: Application
    Filed: September 14, 2010
    Publication date: July 5, 2012
    Applicant: SANOFI
    Inventor: Gerrit Hauck